The role of topoisomerase II alpha and beta in drug resistance.
Imperial Cancer Research Fund, University of Oxford, John Radcliffe Hospital, U.K.
D
D
Hochhauser
A L
AL
Harris
D003600:Cytosol / Q000502:physiology; D004250:DNA Topoisomerases, Type II / Q000502:physiology*; D015536:Down-Regulation; D004351:Drug Resistance / Q000502:physiology*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D004250:DNA Topoisomerases, Type II